fda announcement semaglutide Hims Inc Oral Semaglutide Gets FDA Approval

Originally approved for the management of type 2 diabetes under brand names like Ozempic, semaglutide has demonstrated significant weight reduction benefits in clinical trials, leading to its approval for weight management in individuals without diabetes

They peak during dose escalation and diminish within a few weeks of stabilizing at 15 mg

We discuss body composition considerations in more detail in Semaglutide & Exercise: How to Maximize Fat Loss Without Losing Muscle

Schedule a free consultation to discuss your goals and how we can achieve them together

Glucagon activation increases energy expenditure (meaning your body burns more calories at rest) and accelerates fat oxidation, particularly in the liver

Increasing the dose of a GLP-1 can sometimes enhance weight loss or maintain consistent weight loss, explained Fatima Cody Stanford, MD, an obesity medicine scientist at Massachusetts General Hospital Digestive Healthcare Center in Boston